# Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients

> **NCT07441226** · PHASE2 · RECRUITING · sponsor: **RSUP Persahabatan** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **GENETIC:** Umbilical Cord Mesenchymal Stem Cells
- **DRUG:** Normal saline placebo

## Key facts

- **NCT ID:** NCT07441226
- **Lead sponsor:** RSUP Persahabatan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-08
- **Primary completion:** 2027-12
- **Final completion:** 2028-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07441226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07441226, "Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07441226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*